INTRODUCTIONThe evolution of site-specific cell-targeted drug delivery systems chemically programmed to bind with a single cellular receptor have recently emerged as enablers toward delivering topical skin therapy. New technologies now…

INTRODUCTIONPsoriasis is a polygenic, interleukin (IL)-17 and IL-23 driven chronic relapsing inflammatory multisystem disease caused by a complex interplay of endogeneous and environmental factors resulting in accelerated epidermal proliferation.1 According…

INTRODUCTIONPsoriasis is a chronic inflammatory skin disease characterized by raised erythematous plaques with silvery scales.1 Psoriasis is common, affecting ~2% of the population, and is associated with reduced quality of…

INTRODUCTIONScalp, nail, and palmoplantar psoriasis are highly prevalent among psoriasis patients and often lead to greater impairment of patients’ quality of life (QoL).1 Up to half of patients with psoriasis…

Dear Editor, COVID-19 (also known as SARS-CoV2), a novel coronavirus related to the prior SARS and MERS outbreaks, emerged as a worldwide health threat in winter 2019 and throughout 2020.…

INTRODUCTIONOnabotulinumtoxin A’s (BoNTA’s) clinical utility was first proven in the late 1960s, when it was used for the correction of nonaccommodative strabismus. Since then, the use of BoNTA as a…

INTRODUCTIONDue to increasing diversity of the United States, with an estimated 50 percent of the population identifying as non-white by the year 2050,1 it is imperative to improve medical knowledge…